FDA Approved: CARBAGLU — Original Application (Recordati Rare Diseases)

View source ↗

Summary

CARBAGLU (carbaglumic acid) was approved by the FDA in an original application to treat hyperammonemia due to N-acetylglutamate synthetase deficiency (NAGS defi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• N-acetylglutamate Synthetase Deficiency

Drugs mentioned

• Carbaglu (carglumic acid)

Snippet

ORIG AP for CARBAGLU (CARGLUMIC ACID)